TNYA vs TROW · rev $1.3M vs P/E 12, rev $3.76B
Tenaya Therapeutics Inc (TNYA) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Tenaya Therapeutics Inc (TNYA) is a biotechnology company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported TNYA revenue for 2026-06-30 was $1.3M. Net income was -$62.7M. TNYA currently screens at market cap $156.0M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
TNYA currently screens at market cap $156.0M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the TNYA and TROW stock pages for the full models.
Not investment advice.